Association between visit-to-visit variability of glycemic indices and lipid profile and the incidence of coronary heart disease in adults with type 2 diabetes.

Blood pressure CHD Coronary heart disease Glycemic indices HbA1c Lipid profile Type 2 diabetes mellitus Variability

Journal

Journal of diabetes and metabolic disorders
ISSN: 2251-6581
Titre abrégé: J Diabetes Metab Disord
Pays: Switzerland
ID NLM: 101590741

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 12 07 2021
accepted: 23 10 2021
entrez: 13 12 2021
pubmed: 14 12 2021
medline: 14 12 2021
Statut: epublish

Résumé

Coronary heart disease (CHD) is one of the major causes of mortality and morbidity in patients with type 2 diabetes mellitus. In this study, we aimed to assess the association between visit-to-visit variability of fasting blood sugar (FBS), HbA1c, blood sugar 2 h post-prandial (BS2hpp), lipid indices, creatinine, systolic and diastolic blood pressure (SBP, DBP) and incident CHD in patients with type 2 diabetes during a median follow-up of ten years. The current case-cohort study consisted of 1500 individuals with type 2 diabetes, followed up for the occurrence of CHD from 2002 to 2019. The patients had at least four annual follow-ups during which glycemic and lipid profile were measured. Co-efficient of variance (CV) for each parameter was calculated by 10-21 measurements. Cox regression analysis was performed to assess the association between CV of glycemic indices, lipid profile, blood pressure, creatinine, weight and incident CHD during the follow-up period. Hazard ratios (HR) were adjusted for the confounding variables. Glycemic indices variability (i.e., CV-HbA1c, CV-FBS, and CV-BS2hpp), were significantly higher in the group with incident CHD (P=0.034, P=0.042, and P=0.044, respectively). Hazard ratios were 1.42 (95 % CI=1.13-2.09) for CV-HbA1c, 1.37 (95 % CI=1.02-2.10) for CV-FBS, and 1.16 (95 % CI=1.01-1.63) for CV-BS2hpp (P=0.012, P=0.046, P=0.038, respectively). Creatinine was significantly higher in the group with incident CHD (P=0.036) and it was significantly associated with higher incidence of CHD (HR=1.14, 95 % CI=1.02-2.17, P=0.048). Visit to visit variability of glycemic indices of the patients with type 2 diabetes is associated with incident CHD independent of their baseline and mean values.

Identifiants

pubmed: 34900821
doi: 10.1007/s40200-021-00930-z
pii: 930
pmc: PMC8630209
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1715-1723

Informations de copyright

© Springer Nature Switzerland AG 2021.

Déclaration de conflit d'intérêts

Conflict of interestNone.

Références

Aging Male. 2020 Dec;23(5):906-910
pubmed: 31156011
PLoS One. 2015 Jun 08;10(6):e0129265
pubmed: 26053836
QJM. 2015 Oct;108(10):781-7
pubmed: 25636343
Sci Rep. 2019 Feb 4;9(1):1374
pubmed: 30718626
Diabetol Metab Syndr. 2014 Jun 30;6:76
pubmed: 25013458
Eur Heart J. 2017 Dec 21;38(48):3560-3566
pubmed: 29069458
Swiss Med Wkly. 2019 Oct 27;149:w20139
pubmed: 31656034
JAMA. 2006 Apr 12;295(14):1681-7
pubmed: 16609090
JAMA. 2006 Apr 12;295(14):1707-8
pubmed: 16609094
Eur J Clin Invest. 2020 Mar;50(3):e13206
pubmed: 31999832
J Coll Physicians Surg Pak. 2018 Nov;28(11):844-847
pubmed: 30369376
Diabetes Care. 2015 Feb;38(2):249-56
pubmed: 25414153
Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):15-21
pubmed: 19364638
Hypertension. 2018 Oct;72(4):1002-1010
pubmed: 30354707
Circulation. 2002 Oct 15;106(16):2067-72
pubmed: 12379575
Diabetes Care. 2007 Jan;30(1):162-72
pubmed: 17192355
Aging Male. 2020 Dec;23(5):1098-1102
pubmed: 31615320
Diabetes Obes Metab. 2020 Oct;22(10):1777-1788
pubmed: 32452623
J Hypertens Suppl. 1992 Aug;10(6):S73-7
pubmed: 1432333
Diabetes Obes Metab. 2019 Dec;21(12):2587-2598
pubmed: 31282073
Endocrinol Diabetes Metab. 2020 Jun 08;3(3):e00135
pubmed: 32704558
J Diabetes Metab Disord. 2017 Nov 14;16:45
pubmed: 29164077
Biochem Biophys Res Commun. 2006 Nov 10;350(1):195-201
pubmed: 16997277
Diabetes Care. 2019 Jan;42(1):134-141
pubmed: 30352898
Arch Ophthalmol. 1984 Apr;102(4):527-32
pubmed: 6367725
Circulation. 2005 Jul 5;112(1):25-31
pubmed: 15983251
J Diabetes Complications. 2006 Mar-Apr;20(2):75-80
pubmed: 16504835
J Am Coll Cardiol. 2015 Apr 21;65(15):1539-48
pubmed: 25881936
Rev Assoc Med Bras (1992). 2019 Jan;65(1):38-42
pubmed: 30758418
Diabetologia. 2009 May;52(5):952-61
pubmed: 19263033
Diabetes. 2008 May;57(5):1349-54
pubmed: 18299315
Bratisl Lek Listy. 2021;122(2):116-119
pubmed: 33502879
J Am Heart Assoc. 2017 Nov 29;6(12):
pubmed: 29187392
Cardiovasc Diabetol. 2018 Feb 24;17(1):33
pubmed: 29477146
Diabetes Care. 2009 Aug;32(8):1440-6
pubmed: 19401445
Curr Vasc Pharmacol. 2012 Nov;10(6):684-6
pubmed: 23259553
Cardiovasc Diabetol. 2016 May 21;15:79
pubmed: 27208906
N Engl J Med. 1991 Jun 27;324(26):1839-44
pubmed: 2041550
Atherosclerosis. 2015 Feb;238(2):370-9
pubmed: 25558032
Diabetes Metab Res Rev. 2008 Jul-Aug;24(5):353-63
pubmed: 18461635

Auteurs

Fatemeh Moosaie (F)

Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.

Marjan Mouodi (M)

Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.

Ali Sheikhy (A)

Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.

Aida Fallahzadeh (A)

Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.

Niloofar Deravi (N)

Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Soghra Rabizadeh (S)

Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.

Seyede Marzie Fatemi Abhari (SM)

Department of Pediatrics, Imam Ali Hospital, Alborz University of Medical Sciences, Karaj, Iran.

Alipasha Meysamie (A)

Department of Community Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Fatemeh Dehghani Firouzabadi (F)

Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.

Manouchehr Nakhjavani (M)

Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.

Alireza Esteghamati (A)

Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.

Classifications MeSH